Glucocorticoid Sparing of Benralizumab in Asthma REPLY

被引：0
|
作者：
Nair, Parameswaran [1 ]
Barker, Peter [2 ]
Goldman, Mitchell [2 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
[2] AstraZeneca, Gaithersburg, MD USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1205 / 1205
页数：1
相关论文
共 50 条
  • [1] Oral Glucocorticoid-Sparing Effect of Benralizumab in Severe Asthma
    Nair, Parameswaran
    Wenzel, Sally
    Rabe, Klaus F.
    Bourdin, Arnaud
    Lugogo, Njira L.
    Kuna, Piotr
    Barker, Peter
    Sproule, Stephanie
    Ponnarambil, Sandhia
    Goldman, Mitchell
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (25): : 2448 - 2458
  • [2] Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis
    Padoan, Roberto
    Bianchi, Fulvia Chieco
    Marchi, Maria Rita
    Cazzador, Diego
    Felicetti, Mara
    Emanuelli, Enzo
    Vianello, Andrea
    Nicolai, Piero
    Doria, Andrea
    Schiavon, Franco
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (09): : 3225 - +
  • [3] Real-world oral glucocorticoid-sparing effect of benralizumab in severe asthma
    Jackson, David
    Roxas, Cris
    Thompson, Louise
    Fernandes, Mariana
    Green, Linda
    Kavanagh, Joanne
    Nanzer-Kelly, Alexandra
    D'Ancona, Grainne
    Kent, Brian
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] In severe asthma, benralizumab reduced daily oral glucocorticoid dose and asthma exacerbations at 6 months
    Maselli, Diego J.
    Peters, Jay I.
    ANNALS OF INTERNAL MEDICINE, 2017, 167 (08) : JC43 - JC43
  • [5] Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
    Bel, Elisabeth H.
    Wenzel, Sally E.
    Thompson, Philip J.
    Prazma, Charlene M.
    Keene, Oliver N.
    Yancey, Steven W.
    Ortega, Hector G.
    Pavord, Ian D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (13): : 1189 - 1197
  • [6] Benralizumab for the treatment of asthma
    Matera, M. G.
    Rogliani, P.
    Calzetta, L.
    Canonica, G. W.
    Cazzola, M.
    DRUGS OF TODAY, 2017, 53 (12) : 633 - 645
  • [7] Benralizumab for the treatment of asthma
    Saco, Tara Vinyette
    Pepper, Amber N.
    Lockey, Richard F.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (05) : 405 - 413
  • [8] Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthma
    Bourdin, Arnaud
    Shaw, Dominick
    Menzies-Gow, Andrew
    FitzGerald, J. Mark
    Bleecker, Eugene R.
    Busse, William W.
    Ferguson, Gary T.
    Brooks, Laura
    Barker, Peter
    Garcia Gil, Esther
    Martin, Ubaldo J.
    JOURNAL OF ASTHMA, 2021, 58 (04) : 514 - 522
  • [9] STEROIDS AND STEROID-SPARING AGENTS IN ASTHMA - REPLY
    MULLARKEY, MF
    BAILEY, GA
    BLUMENSTEIN, BA
    ANDRADE, WP
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10): : 652 - 652
  • [10] Benralizumab: for asthma, not yet for COPD
    Fabbri, Leonardo M.
    LANCET RESPIRATORY MEDICINE, 2014, 2 (11): : 862 - 863
12345